Calcium Oxalate Labs, Inc. Introduces VELOXATM: Very Low Oxalate Teas for a Healthier Lifestyle*

December 2, 2024 6:00 AM

Calcium Oxalate Labs, Inc., the proud maker of Kidney C.O.P. Calcium Oxalate Protector, is excited to announce the launch of VELOXA®, a line of Very Low Oxalate Teas. These specially crafted, proprietary tea blends cater to individuals managing their oxalate intake who want to enjoy a flavorful cup of tea.VELOXA® Devine Cranberry Low Oxalate EnchinaceaCarton of 30 Pyramid Tea Bags TEAS LOW IN OXALATE AND TASTE GREAT!Until now, enjoying tea...

Read more

Extraordinary General Meeting in Cantargia AB (publ)

December 2, 2024 5:20 AM

LUND, SE / ACCESSWIRE / December 02, 2024 / Cantargia (STO:CANTA) Cantargia's extraordinary general meeting on December 2, 2024, resolved to approve the board's resolution from November 6, 2024 to increase the company's share capital through the issuance of new shares with pre-emptive rights for the company's shareholders. Subscription may also be made without pre-emptive rights, as set forth in the complete issue resolution.Through the rights...

Read more

BioNxt Solutions Announces Development of Sublingual Thin-Film for Semaglutide

December 2, 2024 3:05 AM

BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), a bioscience company specializing in advanced drug delivery systems, announces the development of a sublingual thin-film oral dissolvable film (ODF) for Semaglutide, internally identified as BNT24005. This innovative product is intended to address limitations of existing administration methods for a therapeutic developed by Novo Nordisk, with the aim of...

Read more

Global Pharma-Grade Synthetic Camphor Market Poised for Strong Growth, Estimated to Reach USD 652.4 Million by 2034 Driven by Growing Demand in Pharma and Healthcare | FMI

December 1, 2024 9:00 PM

The global market for pharma-grade synthetic camphor is on an upward trajectory, with projections indicating a rise from USD 449.3 million in 2024 to USD 652.4 million by 2034. This represents a compound annual growth rate (CAGR) of 3.8% over the forecast period between 2024 and 2034. In 2023, the revenue from pharma-grade synthetic camphor was USD 432.8 million, marking a strong year of growth for this essential compound.The sustained growth in...

Read more

At RSNA 2024, AGFA HealthCare Presents RUBEE(R) AI Powered by CARPL Platform

December 1, 2024 9:00 AM

In Chicago, AGFA HealthCare is set to demonstrate the seamless integration of CARPL.ai into AGFA HealthCare Enterprise Imaging, which in turn offers ground-breaking degrees of flexibility that truly empowers radiologists to work smarter - not harder. This expansion of the AGFA HealthCare RUBEE® portfolio allows AGFA HealthCare customers to access CARPL's marketplace of 140 AI applications, testing, deployment and monitoring tools, as a...

Read more

GLG Life Tech Corporation Reports 2024 Third Quarter Financial Results

November 29, 2024 8:35 PM

GLG Life Tech Corporation (TSX:GLG) ("GLG" or the "Company"), a global leader in the agricultural and commercial development of high-quality zero-calorie natural sweeteners, announces financial results for the three and nine months ended September 30, 2024. The complete set of financial statements and management discussion and analysis are available on SEDAR and on the Company's website at www.glglifetech.com.FINANCIAL SUMMARYThe Company...

Read more

1933 Industries Applies for a Management Cease Trade Order

November 29, 2024 5:45 PM

1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF), a Nevada-focused cannabis cultivator and producer, announces that it has filed an application for a Management Cease Trade Order ("MCTO") with the British Columbia Securities Commission, the Company's principal regulator, in accordance with section 8 of National Policy 12-203 Management Cease Trade Orders ("NP 12-203").The Company determined that it will be unable to file its...

Read more

Benefits of BenCura's Fall Prevention Program

November 29, 2024 4:00 PM

KENNESAW, GA / ACCESSWIRE / November 29, 2024 / Falls are often a big issue in skilled nursing facilities. They can result in loss of independence and injury among residents, and it can also cause liability issues for your facility as well as issues with quality ratings and Medicare reimbursement. In today's article, we'll discuss how a fall prevention restorative program through BenCura can help both your residents and your facility.What...

Read more

HUMHEALTH - the Futuristic Technology of Remote Patient Monitoring

November 29, 2024 12:00 PM

The next generation of Humhealth Remote Patient Monitoring software is here, featuring cutting-edge capabilities designed to transform the remote care. This advanced software is meticulously designed to elevate patient care, optimize clinical outcomes, and streamline healthcare operations with a care team-centric workflow.With its focus on real-time monitoring, personalized patient engagement, and seamless collaboration, Humhealth aims to...

Read more

Aptevo Therapeutics Announces 1-for 37 Reverse Stock Split As Part of Nasdaq Compliance Plan

November 29, 2024 9:55 AM

SEATTLE, WA / ACCESSWIRE / November 29, 2024 / Aptevo Therapeutics Inc. (NASDAQ:APVO) ("Aptevo" or the "Company"), today announced that it will conduct a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-37 (the "Reverse Stock Split"). The Reverse Stock Split is expected to become effective on December [3], 2024 at 5:01 p.m. Eastern Time (the "Effective Time"), with shares expected to begin trading on the Nasdaq...

Read more

ATPC Expands Global Market Footprint to Spearhead Medical Innovation with MoUs in Indonesia

November 29, 2024 9:00 AM

NASDAQ-listed AGAPE ATP Corporation ("ATPC"), today announced the signing of three Memorandums of Understanding ("MOUs") with prominent healthcare institutions in Indonesia. This initiative aims to advance medical research, introduce innovative treatment strategies and strengthen training programs to address respiratory diseases such as tuberculosis (TB) and chronic obstructive pulmonary disease (COPD). The signing marks a key milestone in...

Read more

Cantargia Expands the CAN10 Phase 1 Clinical Program Building on Positive Results

November 29, 2024 7:45 AM

LUND, SWEDEN / ACCESSWIRE / November 29, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB; Nasdaq Stockholm:CANTA) today reported initiation of an expanded part of CAN10's phase 1 clinical study to investigate higher dose levels of the antibody. The purpose of this expansion is to build on the good safety, potent effects on biomarkers and pharmacokinetic properties of CAN10. Current data indicate durable effects and potential for treatment...

Read more

Change in Number of Shares and Votes in Ascelia Pharma AB

November 29, 2024 6:00 AM

MALMÖ, SE / ACCESSWIRE / November 29, 2024 / Ascelia Pharma (STO:ACE)During the month of November, the number of shares and votes in Ascelia Pharma AB have changed due to conversion of a total of 26,310 series C shares into a total of 26,310 ordinary shares for delivery of shares to participants in the performance-based share saving program that was adopted by the annual general meeting held on 5 May 2021 (LTI 2021).As of 29 November 2024, the...

Read more

Recharge Health Unveils FlexBeam: A New Approach To Infrared Therapy For Improved Recovery And Healing

November 29, 2024 3:20 AM

Recharge Health, a pioneering company in health technology, is excited to introduce the FlexBeam, an advanced red and near-infrared light therapy device that is designed to accelerate healing and enhance recovery. With the FlexBeam, Recharge Health has redefined the standards of recovery by bringing portable, high-power infrared therapy to consumers, offering them a new approach to pain relief, injury recovery and overall wellness.The FlexBeam...

Read more

Q3 Interim Report July - September 2024

November 29, 2024 2:20 AM

STOCKHOLM, SE / ACCESSWIRE / November 29, 2024 / PMD Device Solutions (FRA:8T0) (STO:PMDS) Press release: Stockholm, 29 November 2024. PMD Device Solutions AB's (PMDS) interim report for July - September 2024 is now available on the company's website, www.pmd-solutions.com.Financial information July - September 2024 (figures in brackets relate to the same period in Q3 2023)Consolidated net sales for the three months are in line with expectations...

Read more

Evotec Announces Change in Management Board

November 29, 2024 2:00 AM

Evotec SE (Frankfurt Stock Exchange: EVT, SDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announced that its Chief Operating Officer, Dr Craig Johnstone, will step down and leave the Company effective 31 December 2024. Dr Johnstone joined Evotec in May 2012 as SVP Drug Discovery and Innovation Efficiency and in April 2015 was named President and Site Head, Evotec (France) SAS. Dr. Johnstone was appointed Global Head, Integrated Drug...

Read more

IRLAB to Present at ABGSC Investor Days on December 4, 2024

November 29, 2024 1:20 AM

GOTHENBURG, SE / ACCESSWIRE / November 29, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, November 29, 2024 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinson's disease, today announced that the company will present at the ABGSC Investor Days on Wednesday, December 4, 2024, in Stockholm, Sweden.Kristina Torfgård, CEO, will participate in the event. The...

Read more

MedMira Reports FY2024 Fourth Quarter and Year End Financial Results

November 28, 2024 11:00 PM

HALIFAX, NS / ACCESSWIRE / November 28, 2024 / MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the financial year ended July 31, 2024.Corporate UpdateIn December 2023, the Company received the 510(k) (FDA) approval for its Reveal® G4 Rapid HIV-1/2 antibody test. The Company's completed clinical trials showed a sensitivity of 100% for HIV-1 and HIV-2 MedMira's Reveal® G4 HIV-1/2 rapid antibody test achieved a...

Read more

Nurse Maria Victoria Juan from The Philippines Wins the Prestigious Aster Guardians Global Nursing Award 2024

November 28, 2024 3:30 PM

Maria Victoria Juan from The Philippines has just been announced as the winner of Aster Guardians Global Nursing Award 2024 and awarded with USD 250,000 at a prestigious award ceremony held in Bengaluru, India. The winner was announced by Dr. Azad Moopen, Founder Chairman of Aster DM Healthcare, in the esteemed presence Ministry and Government officials, distinguished guests and Alisha Moopen, Managing Director and Group CEO - Aster DM...

Read more

DEXIS Attends ADF, Showcases Award-Winning Solutions

November 28, 2024 9:30 AM

The latest AI-powered launches from DEXIS enhance diagnostics and patient care. At ADF, DEXIS showcased its innovative product line, including the new intraoral scanners and imaging products. The conference took place November 26-30 at the Palais des Congrès de Paris in Porte Maillot, France. The company's comprehensive range of award-winning solutions covers a complete digital diagnostic workflow, from intraoral scanning and implant planning to...

Read more